Delivery Order SPE2DB24D3013-SPE2DB26FFFPG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,082.94 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack units) on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,016.43 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-month supply) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price, competitively awarded contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,083.55 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (3-count) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $3,497.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (quantity: 3) on September 19, 2025, with completion targeted for September 22, 2025. This non-set-aside award was made competitively and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $2,948.40 delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-month supply) on September 26, 2025, with completion targeted for September 29, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,507.98 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (three-month supply) on September 23, 2025, with completion targeted for September 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a $1,719.90 delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger prime indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.30 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xulane 150-35 microgram/day contraceptive patches (3-pack). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,691.42 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count packaging). This is a firm fixed-price, non-set-aside contract with a completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the vendor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $5,940.28 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (quantity: 3 units). This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. The contract represents a child order under AmerisourceBergen's larger...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFFPGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,320.01 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack quantity) on October 17, 2025, with completion targeted for October 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. The company's extensive federal contract portfolio demonstrates consistent capability to competitively deliver a wide range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for contraceptive patches exemplifies the routine medical procurement transactions executed through the company's prime vendor agreement with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 10/17/25 |